Light-driven activation of β2-adrenergic receptor signaling by a chimeric rhodopsin containing the β2-adrenergic receptor cytoplasmic loops

被引:117
|
作者
Kim, JM
Hwa, J
Garriga, P
Reeves, PJ
RajBhandary, UL
Khorana, HG
机构
[1] MIT, Dept Biol, Cambridge, MA 02139 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
关键词
D O I
10.1021/bi048328i
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structure-function studies of rhodopsin indicate that both intradiscal and transmembrane (TM) domains are required for retinal binding and subsequent light-induced structural changes in the cytoplasmic domain. Further, a hypothesis involving a common mechanism for activation of G-protein-coupled receptor (GPCR) has been proposed. To test this hypothesis, chimeric receptors were required in which the cytoplasmic domains of rhodopsin were replaced with those of the beta(2)-adrenergic receptor (beta(2)-AR). Their preparation required identification of the boundaries between the TM domain of rhodopsin and the cytoplasmic domain of the beta(2)-AR necessary for formation of the rhodopsin chromophore and its activation by light and subsequent optimal activation of beta(2)-AR signaling. Chimeric receptors were constructed in which the cytoplasmic loops of rhodopsin were replaced one at a time and in combination. In these replacements, size of the third cytoplasmic (EF) loop critically determined the extent of chromophore formation, its stability, and subsequent signal transduction specificity. All the EF loop replacements showed significant decreases in transducin activation, while only minor effects were observed by replacements of the CD and AB loops. Light-dependent activation of beta(2)-AR leading to Gas signaling was observed only for the EF2 chimera, and its activation was further enhanced by replacements of the other loops. The results demonstrate coupling between light-induced conformational changes occurring in the transmembrane domain of rhodopsin and the cytoplasmic domain of the beta(2)-AR.
引用
收藏
页码:2284 / 2292
页数:9
相关论文
共 50 条
  • [31] Crystallizing thinking about the β2-adrenergic receptor
    Shukla, Arun K.
    Sun, Jin-Peng
    Lefkowitz, Robert J.
    MOLECULAR PHARMACOLOGY, 2008, 73 (05) : 1333 - 1338
  • [32] Polymorphisms of the β2-adrenergic receptor.: Reply
    Dishy, V
    Stein, CM
    Wood, AJJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07): : 537 - 538
  • [33] β2-adrenergic receptor polymorphism and venous thromboembolism
    Folsom, Aaron R.
    Peacock, James M.
    Boerwinkle, Eric
    Cushman, Mary
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) : 240 - 240
  • [34] Role of arrestins in trafficking of the β2-adrenergic receptor
    Benovic, JL
    Gagnon, AW
    Goodman, OB
    Gurevich, VV
    Kallal, L
    Krupnick, JG
    Penn, RB
    Santini, F
    Keen, JH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R17 - R17
  • [35] A crystal clear view of the β2-adrenergic receptor
    Robert J Lefkowitz
    Jin-Peng Sun
    Arun K Shukla
    Nature Biotechnology, 2008, 26 : 189 - 191
  • [36] The significance of β2-adrenergic receptor polymorphisms in asthma
    Litonjua, AA
    CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (01) : 12 - 17
  • [37] Neuroprotective effects of α2-adrenergic receptor agonists
    Weber, Bernd
    Steinfath, Markus
    Scholz, Jens
    Bein, Berthold
    DRUG NEWS & PERSPECTIVES, 2007, 20 (03) : 149 - 154
  • [38] Salmeterol response and β2-adrenergic receptor genotype
    Jackson, Catherine
    Lipworth, Brian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (01) : 217 - 218
  • [39] βARK1 directs β2-adrenergic receptor to Gi signaling
    Zhu, WZ
    Zhang, SJ
    Koch, WJ
    Xiao, RP
    CIRCULATION, 2005, 112 (17) : U53 - U54
  • [40] β2-adrenergic receptor signaling mediates corneal epithelial wound repair
    Ghoghawala, Shahed Y.
    Mannis, Mark J.
    Pullar, Christine E.
    Rosenblatt, Mark I.
    Isseroff, R. Rivkah
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (05) : 1857 - 1863